Copyright: ©Author(s) 2026.
World J Psychiatry. Aug 19, 2026; 16(8): 117122
Published online Aug 19, 2026. doi: 10.5498/wjp.v16.i8.117122
Published online Aug 19, 2026. doi: 10.5498/wjp.v16.i8.117122
Table 1 Baseline data comparison, n (%)
| Indicators | Control group (n = 60) | Research group (n = 73) | χ2/t | P value |
| Sex | 0.416 | 0.519 | ||
| Male | 32 (53.33) | 43 (58.90) | ||
| Female | 28 (46.67) | 30 (41.10) | ||
| Age (years) | 63.95 ± 6.24 | 64.18 ± 6.37 | 0.209 | 0.835 |
| Disease duration (months) | 6.62 ± 2.55 | 7.05 ± 3.08 | 0.865 | 0.389 |
| NYHA classification | 0.151 | 0.698 | ||
| Grade I | 25 (41.67) | 28 (38.36) | ||
| Grade II | 35 (58.33) | 45 (61.64) | ||
| Hypertension | 24 (40.00) | 21 (28.77) | 1.856 | 0.173 |
| Diabetes | 13 (21.67) | 17 (23.29) | 0.050 | 0.824 |
| Hyperlipidaemia | 16 (26.67) | 18 (24.66) | 0.070 | 0.792 |
| Educational level | 0.376 | 0.540 | ||
| Below junior college | 33 (55.00) | 44 (60.27) | ||
| Junior college or above | 27 (45.00) | 29 (39.73) |
- Citation: Chu LJ, Lv JN. Sertraline plus psychological intervention for acute myocardial infarction with anxiety-depression comorbidity: Cardiac function, adverse mood, and resilience impacts. World J Psychiatry 2026; 16(8): 117122
- URL: https://www.wjgnet.com/2220-3206/full/v16/i8/117122.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i8.117122